Reduction of blood ethanol levels by the gamma-hydroxybutyric acid receptor antagonist, NCS-382.
The present study demonstrates that the gamma-hydroxybutyric acid receptor antagonist, NCS-382, markedly reduces blood ethanol levels (BELs) in rats when ethanol is administered via the intragastric route, whereas it is completely ineffective when ethanol is injected IP. The reducing effect of NCS-382 on BELs is likely due to a lessened absorption of ethanol from the gastrointestinal tract.